NCT07185503 2025-09-22
Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety
Institute of Hematology & Blood Diseases Hospital, China
Recruiting
Clinical Trials
5 trialsNCT03149055 2025-05-16
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03241550 2024-11-19
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Astellas Pharma Inc
Phase 1 Completed
NCT00413439 2023-05-10
Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
Basilea Pharmaceutica
Phase 2/3 Completed
NCT03019939 2021-10-26
Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia
M.D. Anderson Cancer Center
Phase 2 Completed